<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902275</url>
  </required_header>
  <id_info>
    <org_study_id>42/19</org_study_id>
    <nct_id>NCT03902275</nct_id>
  </id_info>
  <brief_title>Validation of a Quantra Supported Hemotherapy Algorithm in Cardiac Surgery</brief_title>
  <official_title>Validation of a Quantra Supported Hemotherapy Algorithm in Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HemoSonics LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to develop a coagulation algorithm based on Quantra POCT for the
      treatment of coagulopathic cardiac surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to perform a targeted coagulation therapy during intra- and postoperative care of
      cardiosurgical patients, it is necessary to know the hemostatic potential. After blood
      samples have been taken for coagulation diagnosis, they are usually sent to the central
      laboratory. After analysis and validation, the results are transmitted electronically. The
      loss of time due to sample transport, analysis and provision of the results prolongs the time
      required to derive therapeutic measures.

      In recent years, point of care testing (POCT) devices for the diagnosis of coagulopathic
      patients have become increasingly important. In our clinic, POCT devices have been routinely
      used for intra- and postoperative targeted coagulation therapy for years. These include the
      ROTEM delta and Multiplate. For analysis, a whole blood sample is pipetted together with test
      reagents. Depending on the selected reagent, different parts of the coagulation cascade can
      be evaluated and, depending on this, an appropriate therapy can be derived. A coagulation
      algorithm developed in our clinic is based on these measurement results and has been used
      successfully for years for perioperative coagulation management. This algorithm requires
      additional information on the platelet function, which is also carried out as standard on the
      bed side using multi-plate analysis as POCT.

      A new system for whole blood analysis has recently become available on the market. The
      Quantra from HemoSonics also allows the analysis of a whole blood sample on the bed side. Due
      to the cassette structure, the time-consuming and potentially error-prone pipetting of a
      whole blood sample is no longer necessary. The aim of this study is to develop a coagulation
      algorithm based on Quantra POCT for the treatment of coagulopathic cardiac surgery patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    SARS-CoV-2 Pandemic
  </why_stopped>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bloodloss</measure>
    <time_frame>From finishing operation until 24 hours postoperative</time_frame>
    <description>Cumulative bloodloss directly after surgery for 24h Determined by cumulative volume of all drains in millilitres</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlations of parameters between POCT and laboratory parameters.</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Quick</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlations of parameters between POCT and laboratory parameters.</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>prothrombine time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlations of parameters between POCT and laboratory parameters.</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>activated partial thromboplastin time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlations of parameters between POCT and laboratory parameters.</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Firbinogen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlations of parameters between POCT and laboratory parameters.</measure>
    <time_frame>During operation within 24h postoperative</time_frame>
    <description>platelet count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiplate results</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Determin platelet function with TRAP test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiplate results</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Determin platelet function with ASPI test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiplate results</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Determin platelet function with ADP test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time saving by using a cassette</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Influence of a cassette structure in comparison to pipetting with regard to the temporal availability of the measurement results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of blood products</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Cumulative volume of administered fresh frozen plasma, platelet infusion and packed red blood cells in mililitres</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coagulationfactos and procoagulant drugs</measure>
    <time_frame>During operation within 24 hours postoperative</time_frame>
    <description>Cumulative usage of prothrombin complexe concentrate measured in international units, fibrinogen measured in gramm, tranexamic acid measured in gramm, desmopressin measured in microgramm, Calcium measured in gramm, activated factor VII measured in international units</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboembolic complications</measure>
    <time_frame>During operation within 24h postoperative</time_frame>
    <description>Thromboembolic complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>15 years before operation</time_frame>
    <description>Comorbidities</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Quantra</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Evaluation of bloodsamples using the Quantra and Multiplate device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluation of bloodsamples using the ROTEM and Multiplate device</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quantra-Algorithm</intervention_name>
    <description>Hemotherapy based on Quantra-Algorithm</description>
    <arm_group_label>Quantra</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ROTEM-Algorithm</intervention_name>
    <description>Hemotherapy based on Basic-Algorithm</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        &gt;18 years elective operation with cardiac bypass

        Exclusion Criteria:

        participation on another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian J Raimann, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Frankfurt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Weber CF, Zacharowski K, Brün K, Volk T, Martin EO, Hofer S, Kreuer S. [Basic algorithm for Point-of-Care based hemotherapy: perioperative treatment of coagulopathic patients]. Anaesthesist. 2013 Jun;62(6):464-72. doi: 10.1007/s00101-013-2184-8. Review. German.</citation>
    <PMID>23793973</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferrante EA, Blasier KR, Givens TB, Lloyd CA, Fischer TJ, Viola F. A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings. Anesth Analg. 2016 Dec;123(6):1372-1379.</citation>
    <PMID>27224934</PMID>
  </results_reference>
  <results_reference>
    <citation>Viola F, Lin-Schmidt X, Bhamidipati C, Haverstick DM, Walker WF, Ailawadi G, Lawrence MB. Sonorheometry assessment of platelet function in cardiopulmonary bypass patients: Correlation of blood clot stiffness with platelet integrin αIIbβ3 activity, aspirin usage, and transfusion risk. Thromb Res. 2016 Feb;138:96-102. doi: 10.1016/j.thromres.2015.11.036. Epub 2015 Nov 26.</citation>
    <PMID>26688324</PMID>
  </results_reference>
  <results_reference>
    <citation>Huffmyer JL, Fernandez LG, Haghighian C, Terkawi AS, Groves DS. Comparison of SEER Sonorheometry With Rotational Thromboelastometry and Laboratory Parameters in Cardiac Surgery. Anesth Analg. 2016 Dec;123(6):1390-1399.</citation>
    <PMID>27749339</PMID>
  </results_reference>
  <results_reference>
    <citation>Reynolds PS, Middleton P, McCarthy H, Spiess BD. A Comparison of a New Ultrasound-Based Whole Blood Viscoelastic Test (SEER Sonorheometry) Versus Thromboelastography in Cardiac Surgery. Anesth Analg. 2016 Dec;123(6):1400-1407.</citation>
    <PMID>27159065</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johann Wolfgang Goethe University Hospital</investigator_affiliation>
    <investigator_full_name>Dr. med. Florian Raimann</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>bleeding</keyword>
  <keyword>point of care testing</keyword>
  <keyword>POCT</keyword>
  <keyword>algorithm based therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

